SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-212653
Filing Date
2017-06-26
Accepted
2017-06-26 11:16:02
Documents
7
Effectiveness Date
2017-06-26

Document Format Files

Seq Description Document Type Size
1 DEFA14A d409017ddefa14a.htm DEFA14A 40343
2 GRAPHIC g409017g04p28.jpg GRAPHIC 2542
3 GRAPHIC g409017g06y56.jpg GRAPHIC 1227
4 GRAPHIC g409017g31v43.jpg GRAPHIC 1320
5 GRAPHIC g409017g63q22.jpg GRAPHIC 1340
6 GRAPHIC g409017g84a06.jpg GRAPHIC 1316
7 GRAPHIC g409017snap0013.jpg GRAPHIC 1939
  Complete submission text file 0001193125-17-212653.txt   55601
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35409 | Film No.: 17929137
SIC: 2834 Pharmaceutical Preparations